Evidence map›Paper›PMID 18973810›Full record

ReviewTransplant immunology2009

Xenotransplantation: the next generation of engineered animals.

Anthony J F d'Apice, Peter J Cowan

Abstract readReview
In one paragraph

Review in Transplant immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Immunobiology of liver xenotransplantation.Expert review of clinical immunology · 2012
    Review
  6. Cardiac xenotransplantation: progress and challenges.Current opinion in organ transplantation · 2012
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anthony J F d'ApiceImmunology Research Centre & Department of Medicine, University of Melbourne St. Vincent's Hospital 41 Victoria Parade Fitzroy, Victoria, Australia. Anthony.DAPICE@svhm.org.au
Peter J Cowan

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
Thromboregulatory strategies to prolong xenograft survival.U01AI066331 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROBSON, SIMON C. · 2005 to 2009
$4.1M
NIAID NIH HHS P01 AI045897NIAID NIH HHS U01 AI066331
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Transplantation, HeterologousAnimalsAnimals, Genetically ModifiedComplement System ProteinsDisease Models, AnimalEndogenous RetrovirusesGenetic EngineeringGraft RejectionHumansPrimatesRetroviridae InfectionsSwineTransplantsTrisaccharidesalpha-galactosyl epitopeComplement System ProteinsTrisaccharides

Identifiers

PMID18973810
PMCPMC2727646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.